オンコリスバイオファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/02/06 | 1,745 | 1,937 | 1,700 | 1,873 | +95 | +5.3% | 2,009,400 |
| 2026/02/05 | 1,728 | 1,862 | 1,710 | 1,778 | +70 | +4.1% | 1,195,500 |
| 2026/02/04 | 1,726 | 1,731 | 1,662 | 1,708 | -18 | -1% | 692,500 |
| 2026/02/03 | 1,748 | 1,791 | 1,704 | 1,726 | +45 | +2.7% | 1,268,000 |
| 2026/02/02 | 1,749 | 1,777 | 1,636 | 1,681 | -58 | -3.3% | 897,800 |
| 2026/01/30 | 1,714 | 1,815 | 1,670 | 1,739 | +29 | +1.7% | 1,160,600 |
| 2026/01/29 | 1,765 | 1,777 | 1,657 | 1,710 | +145 | +9.3% | 1,756,400 |
| 2026/01/28 | 1,649 | 1,649 | 1,528 | 1,565 | -52 | -3.2% | 927,600 |
| 2026/01/27 | 1,655 | 1,662 | 1,582 | 1,617 | -21 | -1.3% | 742,700 |
| 2026/01/26 | 1,728 | 1,775 | 1,620 | 1,638 | -170 | -9.4% | 1,714,200 |
| 2026/01/23 | 1,699 | 1,849 | 1,670 | 1,808 | +62 | +3.6% | 2,554,400 |
| 2026/01/22 | 1,947 | 1,952 | 1,738 | 1,746 | -161 | -8.4% | 1,899,700 |
| 2026/01/21 | 1,936 | 2,038 | 1,806 | 1,907 | -147 | -7.2% | 2,892,300 |
| 2026/01/20 | 2,081 | 2,111 | 1,968 | 2,054 | -119 | -5.5% | 2,137,600 |
| 2026/01/19 | 2,100 | 2,235 | 2,005 | 2,173 | +230 | +11.8% | 3,744,600 |
| 2026/01/16 | 1,806 | 1,943 | 1,806 | 1,943 | +225 | +13.1% | 2,718,100 |
| 2026/01/15 | 1,632 | 1,733 | 1,621 | 1,718 | +53 | +3.2% | 1,539,800 |
| 2026/01/14 | 1,559 | 1,726 | 1,545 | 1,665 | +104 | +6.7% | 3,161,200 |
| 2026/01/13 | 1,559 | 1,630 | 1,485 | 1,561 | +42 | +2.8% | 2,412,500 |
| 2026/01/09 | 1,560 | 1,605 | 1,445 | 1,519 | -76 | -4.8% | 2,529,900 |
| 2026/01/08 | 1,505 | 1,640 | 1,474 | 1,595 | +65 | +4.2% | 4,921,000 |
| 2026/01/07 | 1,310 | 1,553 | 1,296 | 1,530 | +168 | +12.3% | 4,463,300 |
| 2026/01/06 | 1,434 | 1,484 | 1,318 | 1,362 | -132 | -8.8% | 5,809,000 |
| 2026/01/05 | 1,440 | 1,630 | 1,422 | 1,494 | +110 | +7.9% | 14,119,000 |
| 2025/12/30 | 1,267 | 1,415 | 1,240 | 1,384 | +267 | +23.9% | 19,080,500 |
| 2025/12/29 | 1,085 | 1,150 | 1,058 | 1,117 | +16 | +1.5% | 4,562,200 |
| 2025/12/26 | 957 | 1,103 | 934 | 1,101 | +148 | +15.5% | 6,542,400 |
| 2025/12/25 | 909 | 958 | 902 | 953 | +63 | +7.1% | 1,649,200 |
| 2025/12/24 | 856 | 908 | 843 | 890 | +29 | +3.4% | 1,667,000 |
| 2025/12/23 | 911 | 934 | 844 | 861 | -54 | -5.9% | 2,080,200 |
| 2025/12/22 | 880 | 958 | 861 | 915 | +56 | +6.5% | 3,452,400 |
| 2025/12/19 | 801 | 882 | 800 | 859 | +43 | +5.3% | 2,555,100 |
| 2025/12/18 | 780 | 858 | 756 | 816 | +36 | +4.6% | 4,027,000 |
| 2025/12/17 | 840 | 864 | 780 | 780 | -50 | -6% | 3,311,600 |
| 2025/12/16 | 901 | 921 | 790 | 830 | -110 | -11.7% | 9,495,000 |
| 2025/12/15 | 1,081 | 1,162 | 890 | 940 | -121 | -11.4% | 20,312,000 |
| 2025/12/12 | 918 | 1,061 | 901 | 1,061 | +150 | +16.5% | 6,753,800 |
| 2025/12/11 | 922 | 932 | 905 | 911 | -26 | -2.8% | 712,400 |
| 2025/12/10 | 941 | 949 | 915 | 937 | -2 | -0.2% | 836,600 |
| 2025/12/09 | 991 | 1,004 | 931 | 939 | -58 | -5.8% | 1,309,000 |
| 2025/12/08 | 921 | 1,005 | 905 | 997 | +74 | +8% | 1,414,900 |
| 2025/12/05 | 939 | 957 | 904 | 923 | -31 | -3.2% | 1,522,400 |
| 2025/12/04 | 1,009 | 1,031 | 951 | 954 | -72 | -7% | 1,643,000 |
| 2025/12/03 | 985 | 1,043 | 945 | 1,026 | +11 | +1.1% | 1,949,000 |
| 2025/12/02 | 1,090 | 1,128 | 1,001 | 1,015 | -105 | -9.4% | 2,200,400 |
| 2025/12/01 | 1,175 | 1,187 | 1,094 | 1,120 | -54 | -4.6% | 1,396,200 |
| 2025/11/28 | 1,151 | 1,197 | 1,135 | 1,174 | +6 | +0.5% | 2,177,200 |
| 2025/11/27 | 1,029 | 1,171 | 1,019 | 1,168 | +127 | +12.2% | 2,192,500 |
| 2025/11/26 | 965 | 1,050 | 955 | 1,041 | +76 | +7.9% | 1,917,000 |
| 2025/11/25 | 1,006 | 1,008 | 940 | 965 | -21 | -2.1% | 1,299,600 |
1～
50
件表示中 / 2972件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| オンコリス | 216,300円 | +3125.8% | - | 0.00% | - | 44.25倍 |
|
腫瘍溶解ウイルス食道がん治療薬「テロメライシン」開発が柱。導出神経難病薬は米国治験中 |
| クオリプス | 821,000円 | +237.1% | - | 0.00% | - | 13.14倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| タウンズ | 55,800円 | +11.5% | -0.9% | 5.02% | 6.89倍 | 3.41倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| 富士製薬 | 217,200円 | +14.7% | +31.9% | 2.16% | 23.71倍 | 1.13倍 |
|
女性医療に強い。後発薬から新薬へシフト中。バイオ後続品に注力。子会社通じ海外展開も |
| ハートシード | 188,800円 | +246.7% | - | 0.00% | 188.23倍 | 5.74倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム
